← Back to signals
IDXX
AVOIDIDEXX Laboratories Inc.
Health Care
1.91
PEGY ratio
Rank #348
Why This Matters
This stock appears overvalued relative to its growth and dividend yield. Strong projected growth of 21.6% annually over 5 years.
IDXX trades at 41.4x earnings against 21.6% growth (no dividend) (PEGY 1.91). The valuation appears stretched relative to the available growth and income.
~ Growth estimate uses historical CAGR (forward estimates unavailable)
- • Growth rate derived from historical CAGR — limited analyst coverage.
Scan date: 2026-06-19
Valuation
41.4x
P/E Ratio
Growth
21.6%
5yr EPS
Income
0.0%
Div Yield
PEGY Components
PEGY Score1.91
Denominator21.6%
EPS (TTM)$13.58
Market Data
Price$562.09
ExchangeNASDAQ
S&P 500Nasdaq 100
What Changed
PEGY Score
1.90→1.91(+0.01)
Rank
#346→#348(2 positions)
vs 7 days ago
Portfolio Context
Founder does not hold this stock.
Not in your portfolio.
Sector: Health Care
PEGY History — 90 days
Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only